speb/financial-data huggingface dataset:
IMXI income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 31406360.00
IMXI income_statement (annual, 2024-12-31) — Diluted EPS: 1.79
IMXI income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.49
IMXI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 58821000.00
IMXI income_statement (annual, 2024-12-31) — EBIT: 95016000.00
IMXI income_statement (annual, 2024-12-31) — EBITDA: 108661000.00
IMXI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -3635000.00
IMXI cash_flow (annual, 2024-12-31) — End Cash Position: 130503000.00
IMXI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -114204000.00
IMXI cash_flow (annual, 2024-12-31) — Free Cash Flow: 23088000.00
IMXI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 1592000.00
IMXI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1446000.00
IMXI income_statement (annual, 2024-12-31) — General And Administrative Expense: 109730000.00
IMXI balance_sheet (annual, 2024-12-31) — Goodwill: 55195000.00
IMXI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 82042000.00
IMXI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 110623000.00
IMXI balance_sheet (annual, 2024-12-31) — Gross PPE: 126933000.00
IMXI income_statement (annual, 2024-12-31) — Gross Profit: 229681000.00
IMXI cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 24591000.00
IMXI income_statement (annual, 2024-12-31) — Interest Expense: 11745000.00
IMXI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 11745000.00
IMXI cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 10430000.00
IMXI balance_sheet (annual, 2024-12-31) — Invested Capital: 291547000.00
IMXI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -43946000.00
IMXI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3019200000.00
IMXI balance_sheet (annual, 2024-12-31) — Land And Improvements: 36000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 36000.00
IMXI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 18582000.00
IMXI balance_sheet (annual, 2024-12-31) — Long Term Debt: 156623000.00
IMXI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 175205000.00
IMXI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3019200000.00
IMXI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3052069000.00
IMXI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 93228000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 93228000.00
IMXI cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -13949000.00
IMXI cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -12150000.00
IMXI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -75132000.00
IMXI balance_sheet (annual, 2024-12-31) — Net Debt: 26120000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Net Debt: 26120000.00
IMXI income_statement (annual, 2024-12-31) — Net Income: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 58821000.00
IMXI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 58821000.00
IMXI income_statement (annual, 2024-12-31) — Net Interest Income: -11745000.00
IMXI cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 0.00
IMXI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -32869000.00
IMXI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -32869000.00
IMXI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -11745000.00
IMXI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -5534000.00
IMXI cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1332000.00
IMXI balance_sheet (annual, 2024-12-31) — Net PPE: 68865000.00
IMXI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -29997000.00
IMXI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 52882000.00
IMXI balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 2198000.00
IMXI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 250000.00
IMXI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 250000.00
IMXI balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 3702000.00
IMXI income_statement (annual, 2024-12-31) — Normalized EBITDA: 113540000.00
IMXI income_statement (annual, 2024-12-31) — Normalized Income: 62265574.00
IMXI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 53085000.00
IMXI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1592000.00
IMXI income_statement (annual, 2024-12-31) — Operating Income: 99895000.00
IMXI income_statement (annual, 2024-12-31) — Operating Revenue: 643745000.00
IMXI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 30548702.00
IMXI balance_sheet (annual, 2024-12-31) — Other Current Assets: 1876000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2402000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1446000.00
IMXI income_statement (annual, 2024-12-31) — Other Gand A: 41483000.00
IMXI income_statement (annual, 2024-12-31) — Other Income Expense: -4879000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 26847000.00
IMXI cash_flow (annual, 2024-12-31) — Other Non Cash Items: 8444000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 7787000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Payable: 103124000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Properties: 33011000.00
IMXI balance_sheet (annual, 2024-12-31) — Other Receivables: 2087000.00
IMXI balance_sheet (annual, 2024-12-31) — Payables: 125609000.00
IMXI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 140436000.00
IMXI balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IMXI balance_sheet (annual, 2024-12-31) — Prepaid Assets: 56240000.00
IMXI income_statement (annual, 2024-12-31) — Pretax Income: 83271000.00
IMXI cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -669000.00
IMXI balance_sheet (annual, 2024-12-31) — Properties: 0.00
IMXI balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
IMXI income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 6411000.00
IMXI cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 6411000.00
IMXI cash_flow (annual, 2024-12-31) — Purchase Of Business: -13949000.00
IMXI cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -12150000.00
IMXI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -29997000.00
IMXI balance_sheet (annual, 2024-12-31) — Receivables: 109164000.00
IMXI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 428968000.00
IMXI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 13645000.00
IMXI cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3052069000.00
IMXI cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -75132000.00
IMXI income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 4879000.00
IMXI balance_sheet (annual, 2024-12-31) — Retained Earnings: 257470000.00
IMXI income_statement (annual, 2024-12-31) — Salaries And Wages: 68247000.00
IMXI cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 0.00
IMXI income_statement (annual, 2024-12-31) — Selling General And Administration: 109730000.00
IMXI balance_sheet (annual, 2024-12-31) — Share Issued: 40164056.00
IMXI income_statement (annual, 2024-12-31) — Special Income Charges: -4879000.00
IMXI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 7043000.00
IMXI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 134924000.00
IMXI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 52882000.00
IMXI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1434426.00
IMXI income_statement (annual, 2024-12-31) — Tax Provision: 24450000.00
IMXI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.29
IMXI balance_sheet (annual, 2024-12-31) — Total Assets: 462377000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Capitalization: 291547000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Debt: 181673000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 134924000.00
IMXI income_statement (annual, 2024-12-31) — Total Expenses: 558754000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 327453000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 164594000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 175455000.00
IMXI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 95016000.00
IMXI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2965000.00
IMXI income_statement (annual, 2024-12-31) — Total Unusual Items: -4879000.00
IMXI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -4879000.00
IMXI balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 9615354.00
IMXI balance_sheet (annual, 2024-12-31) — Treasury Stock: 200696000.00
IMXI balance_sheet (annual, 2024-12-31) — Working Capital: 145785000.00
IMXI income_statement (quarterly, 2025-03-31) — +Operating Expense: 34972000.00
IMXI income_statement (quarterly, 2025-03-31) — +Total Revenue: 144310000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 23410000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 131026000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -14000000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 80775000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4095000.00
IMXI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30587949.00
IMXI income_statement (quarterly, 2025-03-31) — Basic EPS: 0.25
IMXI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 130503000.00
IMXI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5313000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 23885000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 151764000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 151764000.00
IMXI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -15145000.00
IMXI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5313000.00
IMXI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 41282000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 3977000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1993000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Payable: 33751000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 33751000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 17877000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -25911000.00
IMXI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 23724000.00
IMXI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -25911000.00
IMXI cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20824000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Common Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 139243000.00
IMXI cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4981000.00
IMXI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 93788000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 13886000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Assets: 325928000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6392000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6392000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2039000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2039000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 186468000.00
IMXI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -268000.00
IMXI cash_flow (quarterly, 2025-03-31) — Deferred Tax: -268000.00
IMXI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3629000.00
IMXI income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 3629000.00
IMXI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3629000.00
IMXI income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3629000.00
IMXI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 30831633.00
IMXI income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.25
IMXI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — EBIT: 14075000.00
IMXI income_statement (quarterly, 2025-03-31) — EBITDA: 17704000.00
IMXI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 437000.00
IMXI cash_flow (quarterly, 2025-03-31) — End Cash Position: 151764000.00
IMXI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -15145000.00
IMXI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 35969000.00
IMXI cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 249000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1098000.00
IMXI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 29277000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Goodwill: 55195000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 81253000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 135121000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 84280000.00
IMXI income_statement (quarterly, 2025-03-31) — Gross Profit: 50522000.00
IMXI cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1294000.00
IMXI income_statement (quarterly, 2025-03-31) — Interest Expense: 2700000.00
IMXI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2700000.00
IMXI cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 2446000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 286628000.00
IMXI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5313000.00
IMXI cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1916000000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17493000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 147385000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 164878000.00
IMXI cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1916000000.00
IMXI cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1925235000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -4981000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7769000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7769000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7769000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -38000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Interest Income: -2700000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -9235000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -9235000.00
IMXI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2700000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Net PPE: 70280000.00
IMXI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5275000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 57990000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 2230000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 18000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 18000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 3469000.00
IMXI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 19179000.00
IMXI income_statement (quarterly, 2025-03-31) — Normalized Income: 8776408.79
IMXI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 41282000.00
IMXI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 249000.00
IMXI income_statement (quarterly, 2025-03-31) — Operating Income: 15550000.00
IMXI income_statement (quarterly, 2025-03-31) — Operating Revenue: 140348000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 30349730.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1316000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2402000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1098000.00
IMXI income_statement (quarterly, 2025-03-31) — Other Gand A: 10989000.00
IMXI income_statement (quarterly, 2025-03-31) — Other Income Expense: -1475000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 26058000.00
IMXI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2001000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 7411000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Payable: 133006000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Properties: 84280000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1944000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Payables: 161749000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 175635000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IMXI balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 39878000.00
IMXI income_statement (quarterly, 2025-03-31) — Pretax Income: 11375000.00
IMXI cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -929000.00
IMXI income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 2066000.00
IMXI cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 2066000.00
IMXI cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -38000.00
IMXI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5275000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Receivables: 132970000.00
IMXI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 93788000.00
IMXI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3629000.00
IMXI cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1925235000.00
IMXI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4981000.00
IMXI income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 1475000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 265239000.00
IMXI income_statement (quarterly, 2025-03-31) — Salaries And Wages: 18288000.00
IMXI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 29277000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Share Issued: 40332957.00
IMXI income_statement (quarterly, 2025-03-31) — Special Income Charges: -1475000.00
IMXI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2112000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 139243000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 57990000.00
IMXI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -467591.21
IMXI income_statement (quarterly, 2025-03-31) — Tax Provision: 3606000.00
IMXI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
IMXI balance_sheet (quarterly, 2025-03-31) — Total Assets: 490589000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 286628000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Debt: 171270000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 139243000.00
IMXI income_statement (quarterly, 2025-03-31) — Total Expenses: 128760000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 351346000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 164661000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 164878000.00
IMXI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 14075000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 5333000.00
IMXI income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1475000.00
IMXI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1475000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 9983227.00
IMXI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 205677000.00
IMXI balance_sheet (quarterly, 2025-03-31) — Working Capital: 139460000.00
IMXI income_statement (quarterly, 2025-06-30) — +Operating Expense: 37191000.00
IMXI income_statement (quarterly, 2025-06-30) — +Total Revenue: 161133000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 26267000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 141651000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -15100000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 82895000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -5146000.00
IMXI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 29843687.00
IMXI income_statement (quarterly, 2025-06-30) — Basic EPS: 0.37
IMXI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 151764000.00
IMXI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4532000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 22642000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 174723000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 174723000.00
IMXI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -14622000.00
IMXI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4720000.00
IMXI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 39902000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2281000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -2126000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Payable: 25449000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 25449000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 9361000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Receivables: -13387000.00
IMXI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 19297000.00
IMXI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -13387000.00
IMXI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 20560000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Common Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 142253000.00
IMXI cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -11353000.00
IMXI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 102257000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 14552000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Assets: 351185000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 6498000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6498000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 543000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 543000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 215486000.00
IMXI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1109000.00
IMXI cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1109000.00
IMXI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4454000.00
IMXI income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 4454000.00
IMXI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4454000.00
IMXI income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 4454000.00
IMXI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29912615.00
IMXI income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.37
IMXI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — EBIT: 19461000.00
IMXI income_statement (quarterly, 2025-06-30) — EBITDA: 23915000.00
IMXI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2399000.00
IMXI cash_flow (quarterly, 2025-06-30) — End Cash Position: 174723000.00
IMXI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -14622000.00
IMXI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 35370000.00
IMXI cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 258000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 138000.00
IMXI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 30879000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Goodwill: 55195000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 82100000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 146797000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 85633000.00
IMXI income_statement (quarterly, 2025-06-30) — Gross Profit: 58876000.00
IMXI cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 10704000.00
IMXI income_statement (quarterly, 2025-06-30) — Interest Expense: 3093000.00
IMXI income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3093000.00
IMXI cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 2838000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 286385000.00
IMXI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4720000.00
IMXI cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2119000000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 16144000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 144132000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 160276000.00
IMXI cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 1925230000.00
IMXI cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -11353000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 11007000.00
IMXI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11007000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Interest Income: -3093000.00
IMXI cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3256000.00
IMXI cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 9230000.00
IMXI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3093000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Net PPE: 70533000.00
IMXI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4570000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 60153000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 2439000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1127000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1127000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 2640000.00
IMXI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 26139000.00
IMXI income_statement (quarterly, 2025-06-30) — Normalized Income: 12502574.78
IMXI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 39902000.00
IMXI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 258000.00
IMXI income_statement (quarterly, 2025-06-30) — Operating Income: 21685000.00
IMXI income_statement (quarterly, 2025-06-30) — Operating Revenue: 156651000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 29424425.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1278000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2895000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 138000.00
IMXI income_statement (quarterly, 2025-06-30) — Other Gand A: 12354000.00
IMXI income_statement (quarterly, 2025-06-30) — Other Income Expense: -2224000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 26905000.00
IMXI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2004000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 7991000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Payable: 161991000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Properties: 85633000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1644000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Payables: 190998000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 205550000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IMXI balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 31889000.00
IMXI income_statement (quarterly, 2025-06-30) — Pretax Income: 16368000.00
IMXI cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -13000.00
IMXI income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: 1858000.00
IMXI cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 1858000.00
IMXI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4570000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Receivables: 143295000.00
IMXI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 102257000.00
IMXI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4454000.00
IMXI cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2122256000.00
IMXI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -11353000.00
IMXI income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 2224000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 276246000.00
IMXI income_statement (quarterly, 2025-06-30) — Salaries And Wages: 18525000.00
IMXI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 30879000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Share Issued: 40387993.00
IMXI income_statement (quarterly, 2025-06-30) — Special Income Charges: -2224000.00
IMXI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2133000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 142253000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 60153000.00
IMXI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -728425.22
IMXI income_statement (quarterly, 2025-06-30) — Tax Provision: 5361000.00
IMXI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.33
IMXI balance_sheet (quarterly, 2025-06-30) — Total Assets: 518015000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 286385000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Debt: 166774000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 142253000.00
IMXI income_statement (quarterly, 2025-06-30) — Total Expenses: 139448000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 375762000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 166830000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 160276000.00
IMXI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 19461000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 2740000.00
IMXI income_statement (quarterly, 2025-06-30) — Total Unusual Items: -2224000.00
IMXI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2224000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 10963568.00
IMXI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 217030000.00
IMXI balance_sheet (quarterly, 2025-06-30) — Working Capital: 135699000.00
IMXI income_statement (quarterly, 2025-09-30) — +Operating Expense: 40397000.00
IMXI income_statement (quarterly, 2025-09-30) — +Total Revenue: 154921000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18328000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 119218000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -16300000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 85527000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -5684000.00
IMXI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 29616788.00
IMXI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.17
IMXI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 174723000.00
IMXI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6868000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 23203000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 151589000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 151589000.00
IMXI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 13629000.00
IMXI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -7472000.00
IMXI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -28675000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -10592000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1942000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Payable: -61631000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -61631000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -4048000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Receivables: 20326000.00
IMXI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -47295000.00
IMXI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 20326000.00
IMXI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -22518000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Common Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 149688000.00
IMXI cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
IMXI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 98636000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 14001000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Assets: 311224000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 6208000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 6208000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
IMXI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 153502000.00
IMXI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1745000.00
IMXI cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1745000.00
IMXI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 4410000.00
IMXI income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 4410000.00
IMXI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 4410000.00
IMXI income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 4410000.00
IMXI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 29816620.00
IMXI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.17
IMXI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — EBIT: 10535000.00
IMXI income_statement (quarterly, 2025-09-30) — EBITDA: 14945000.00
IMXI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -616000.00
IMXI cash_flow (quarterly, 2025-09-30) — End Cash Position: 151589000.00
IMXI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 13629000.00
IMXI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -35543000.00
IMXI cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 604000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -22000.00
IMXI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 33833000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Goodwill: 55195000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 81771000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 124902000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 90271000.00
IMXI income_statement (quarterly, 2025-09-30) — Gross Profit: 56285000.00
IMXI cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 4708000.00
IMXI income_statement (quarterly, 2025-09-30) — Interest Expense: 2981000.00
IMXI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2981000.00
IMXI cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 2720000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 307617000.00
IMXI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7472000.00
IMXI cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2051600000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 16995000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 157929000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 174924000.00
IMXI cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 5000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1011000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
IMXI balance_sheet (quarterly, 2025-09-30) — Net Debt: 6340000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 4963000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 4963000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Interest Income: -2981000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 13805000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 5000.00
IMXI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2981000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Net PPE: 73971000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -6868000.00
IMXI cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 13800000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 67917000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 2340000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 618000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 618000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 2193000.00
IMXI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 20298000.00
IMXI income_statement (quarterly, 2025-09-30) — Normalized Income: 8479936.59
IMXI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -28675000.00
IMXI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 604000.00
IMXI income_statement (quarterly, 2025-09-30) — Operating Income: 15888000.00
IMXI income_statement (quarterly, 2025-09-30) — Operating Revenue: 150073000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 29713211.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1284000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2752000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -22000.00
IMXI income_statement (quarterly, 2025-09-30) — Other Gand A: 14132000.00
IMXI income_statement (quarterly, 2025-09-30) — Other Income Expense: -5353000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 26576000.00
IMXI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1985000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 7233000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Payable: 110100000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Properties: 90271000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1921000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Payables: 130541000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 144542000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IMXI balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 37212000.00
IMXI income_statement (quarterly, 2025-09-30) — Pretax Income: 7554000.00
IMXI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 932000.00
IMXI income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 2154000.00
IMXI cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 2154000.00
IMXI cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1011000.00
IMXI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -6868000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Receivables: 121139000.00
IMXI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 98636000.00
IMXI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 4410000.00
IMXI cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2037795000.00
IMXI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
IMXI income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 5353000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 281209000.00
IMXI income_statement (quarterly, 2025-09-30) — Salaries And Wages: 19701000.00
IMXI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 33833000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Share Issued: 40676779.00
IMXI cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 2051600000.00
IMXI cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -2037800000.00
IMXI income_statement (quarterly, 2025-09-30) — Special Income Charges: -5353000.00
IMXI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2759000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 149688000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 67917000.00
IMXI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1836063.41
IMXI income_statement (quarterly, 2025-09-30) — Tax Provision: 2591000.00
IMXI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.34
IMXI balance_sheet (quarterly, 2025-09-30) — Total Assets: 478732000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 307617000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Debt: 181132000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 149688000.00
IMXI income_statement (quarterly, 2025-09-30) — Total Expenses: 139033000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 329044000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 167508000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 175542000.00
IMXI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 10535000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 2113000.00
IMXI income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5353000.00
IMXI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5353000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 10963568.00
IMXI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 217030000.00
IMXI balance_sheet (quarterly, 2025-09-30) — Working Capital: 157722000.00
IMXI income_statement (annual, 2025-12-31) — +Operating Expense: 150845000.00
IMXI income_statement (quarterly, 2025-12-31) — +Operating Expense: 38285000.00
IMXI income_statement (annual, 2025-12-31) — +Total Revenue: 607776000.00
IMXI income_statement (quarterly, 2025-12-31) — +Total Revenue: 147412000.00
IMXI balance_sheet (annual, 2025-12-31) — Accounts Payable: 15317000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 15317000.00
IMXI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 105369000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 105369000.00
IMXI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -63713000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -63713000.00
IMXI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 87835000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 87835000.00
IMXI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -5530000.00